Trial
NCT00517868
Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Phase IITERMINATEDREGULATORYConfidence: HIGH
Sponsor
Urigen
Collaborators
—
Condition
Painful Bladder Syndrome
Intervention
URG101
Why stopped
The study was terminated due to Food and Drug Administration (FDA) recalled the heparin used in the trial because of possible contamination.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-23